Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center.
暂无分享,去创建一个
P. Vitti | F. Basolo | R. Tuttle | P. Piaggi | R. Elisei | V. Bottici | E. Molinaro | L. Agate | L. Torregrossa | L. Valerio | V. Cappagli | L. Pieruzzi | M. C. Campopiano | A. Matrone | D. Viola | L. Lorusso | C. Giani | L. Puleo
[1] A. Miyauchi,et al. Patient Experience of Thyroid Cancer Active Surveillance in Japan , 2019, JAMA otolaryngology-- head & neck surgery.
[2] T. Daskivich,et al. Parallels Between Low-Risk Prostate Cancer and Thyroid Cancer: A Review , 2019, JAMA oncology.
[3] H. Welch,et al. Saving Thyroids - Overtreatment of Small Papillary Cancers. , 2018, The New England journal of medicine.
[4] A. Vickers,et al. Long‐Term Cancer Specific Anxiety in Men Undergoing Active Surveillance of Prostate Cancer: Findings from a Large Prospective Cohort , 2018, The Journal of urology.
[5] J. McKenney,et al. Rosai and Ackerman's surgical pathology / , 2018 .
[6] K. Higgins,et al. A protocol for a Canadian prospective observational study of decision-making on active surveillance or surgery for low-risk papillary thyroid cancer , 2018, BMJ Open.
[7] R. Tuttle,et al. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management , 2018, Expert review of endocrinology & metabolism.
[8] T. Montesano,et al. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. , 2017, Thyroid : official journal of the American Thyroid Association.
[9] Oscar Lin,et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance , 2017, JAMA otolaryngology-- head & neck surgery.
[10] Michael J Barry,et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement , 2017, JAMA.
[11] Jill O Jin. JAMA patient page. Screening for Thyroid Cancer. , 2017, JAMA.
[12] V. Grégoire,et al. The EORTC module for quality of life in patients with thyroid cancer: phase III. , 2017, Endocrine-related cancer.
[13] David Gillatt,et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.
[14] P. Glasziou,et al. Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Wong,et al. Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation. , 2016, JAMA otolaryngology-- head & neck surgery.
[16] L. Esserman,et al. CLINICAL DECISIONS. Ductal Carcinoma In Situ. , 2016, The New England journal of medicine.
[17] A. Miyauchi,et al. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery , 2016, Thyroid : official journal of the American Thyroid Association.
[18] S. Mandel,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[19] Laura H. Tang,et al. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study , 2016, Annals of Surgical Oncology.
[20] E. Papini,et al. Italian consensus for the classification and reporting of thyroid cytology , 2014, Journal of Endocrinological Investigation.
[21] A. Miyauchi,et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. , 2014, Thyroid : official journal of the American Thyroid Association.
[22] J. Shah,et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. , 2010, Thyroid : official journal of the American Thyroid Association.
[23] I. Sugitani,et al. Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes , 2010, World Journal of Surgery.
[24] The Bethesda System For Reporting Thyroid Cytopathology. , 2009, American journal of clinical pathology.
[25] Robert D Cardiff,et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A. Miyauchi,et al. An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.
[27] A. Miyauchi,et al. Prognosis of Patients with Benign Thyroid Diseases Accompanied by Incidental Papillary Carcinoma Undetectable on Preoperative Imaging Tests , 2007, World Journal of Surgery.
[28] T. Pilli,et al. Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer. , 2005, Thyroid : official journal of the American Thyroid Association.
[29] A. Miyauchi,et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. , 2003, Thyroid : official journal of the American Thyroid Association.
[30] K. Suen. Guidelines of The Papanicolaou Society of Cytopathology for the examination of fine‐needle aspiration specimens from thyroid nodules: The Papanicolaou Society of Cytopathology Task Force on Standards of Practice , 1996, Diagnostic cytopathology.
[31] A Pinchera,et al. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. , 1991, The Journal of clinical endocrinology and metabolism.
[32] L. Sobin,et al. The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.